Related references
Note: Only part of the references are listed.Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS
A. R. Salter et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Contribution of impaired mobility to patient burden in multiple sclerosis
Matthew H. Sutliff
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Patient-centered outcomes Translating clinical efficacy into benefits on health-related quality of life
Deborah Miller et al.
NEUROLOGY (2010)
New perspectives in the natural history of multiple sclerosis
Helen Tremlett et al.
NEUROLOGY (2010)
Economic Burden of Multiple Sclerosis A Systematic Review of the Literature
Huseyin Naci et al.
PHARMACOECONOMICS (2010)
Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) - Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology
D. S. Goodin et al.
NEUROLOGY (2008)
Cognitive impairment and structural brain damage in benign multiple sclerosis
M. Rovaris et al.
NEUROLOGY (2008)
The distribution of the cost of multiple sclerosis in the UK: How do costs vary by illness severity?
David Tyas et al.
VALUE IN HEALTH (2007)
The psychosocial effect of multiple sclerosis: The impact of relapses
June Halper
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial
Jeremy Chataway et al.
LANCET NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
F Sellebjerg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Cost of managing an episode of relapse in multiple sclerosis in the United States
JA O'Brien et al.
BMC HEALTH SERVICES RESEARCH (2003)
Share Paper
